Background illustration for clinical trials search

Paid Clinical Trials Bethesda

Discover 2,413 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Baltimore MD, Fredericksburg VA, Allentown PA,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase3, Recruiting

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

for
Delirium
Location: Baltimore MD, New York NY, The Bronx NY, Durham NC,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 60+

Code: NCT06192615

Phase3, Recruiting

Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures

for
Primary Immune Deficiency Disorder, Immune Deficiency Disease,
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 0 - 50

Code: NCT04232085

Phase2, Recruiting

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

for
Carcinoma, Non-small-Cell Lung
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05498428

Phase2, Recruiting

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

for
Alcoholism, Substance-Related Disorders
Location: Baltimore MD
Sponsor: National Institute on Drug Abuse (NIDA)

Sex: All

Age: 18 - 70+

Code: NCT06676059

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

for
Locally Advanced Malignant Solid Neoplasm,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03907475

Phase2, Recruiting

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostatic Neoplasms
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07164443

Phase3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Rockville MD, Falls Church VA, Vienna VA, Lanham MD,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase3, Recruiting

Measuring Surgical Recovery After Radical Cystectomy

for
Bladder Cancer
Location: Baltimore MD, Rochester NY, Atlanta GA, Chicago IL,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03193970

Recruiting

Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)

for
Autism Spectrum Disorder (ASD)
Location: Baltimore MD, Orange CA
Sponsor: Children's Hospital of Orange County

Sex: Male

Age: 5 - 14

Code: NCT06866275

Phase2, Recruiting

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

for
Neovascular (Wet) Age-Related Macular Degeneration
Location: Hagerstown MD, Bethlehem PA, Boston MA,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT05197270

Phase1, Phase2, Recruiting

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

for
Polymyositis, Dermatomyositis
Location: Baltimore MD, Pittsburgh PA, Great Neck NY, Durham NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06455449

Phase3, Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: Washington D.C. DC, Fairfax VA, Annapolis MD,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase3, Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase2, Recruiting

Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)

for
Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment,
Location: Kensington MD, McLean VA, Rockville MD, Greenbelt MD,
Sponsor: Brainsway

Sex: All

Age: 22 - 68

Code: NCT04455646

Recruiting

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

for
Chronic Kidney Disease (CKD)
Location: Baltimore MD, Philadelphia PA, New York NY, Chicago IL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70

Code: NCT05106387

Recruiting

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

for
Acute Respiratory Distress Syndrome, ARDS
Location: Silver Spring MD, Washington D.C. DC, Flushing NY,
Sponsor: Direct Biologics, LLC

Sex: All

Age: 18 - 70+

Code: NCT05354141

Phase3, Recruiting

Long-Term Stability of the Glide Control Strategy

for
Upper Limb Amputation Above Elbow,
Location: Silver Spring MD, Fairfax VA, Leesburg VA, Annapolis MD,
Sponsor: Infinite Biomedical Technologies

Sex: All

Age: 18+

Code: NCT07222085

Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Fairfax VA, Columbia MD, Charlottesville VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase3, Recruiting

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

for
Amblyopia
Location: Baltimore MD, Lancaster PA, Philadelphia PA, Norfolk VA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 3 - 13

Code: NCT04378790

Phase3, Recruiting